Back to dashboard
Episode 105
DIP Episode 105 - USMLE Step 1 Rapid Review Series 7 (Neuro)
NeurologyMedium4 - HighHas Q&A
Step 1Step 2Step 3NeurologyUSMLEStep 1Step 2Step 3
Topic
Neurodegenerative disorders (AD, CJD); Peripheral and Central Neuropathies (GBS, SMA, MG); Endocrine/Metabolic Disorders (Wilson's disease)...
Key Takeaway
The rapid review emphasizes classic clinical presentations for neurological disorders, requiring differential diagnosis based on specific signs (e.g., myoclonus in CJD, Kayser-Fleischer rings in Wilson's) and precise knowledge of drug toxicities (e.g., INH causing B6 deficiency).
Runtime: 26.1 min
Published: 2019-05-24
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: RAPID REVIEW
Episode Notes
Source / episode info
- Episode: 105
- Title: Divine Intervention Episode 105 – USMLE Step 1 Rapid Review Series 7 (Neuro)
- Published: 2019-05-24
- Source: Episode page
One-liner
This episode provides a rapid review of high-yield neurological topics including dementia syndromes (AD, CJD), neuromuscular junction disorders (MG), peripheral neuropathies (GBS, SMA), and infectious causes of CNS/PNS inflammation (Toxoplasmosis, HSV).
High-yield summary
- Cerebral Demographics: Rapidly progressive dementia with myoclonus in an archaeologist is highly suggestive of Creutzfeldt-Jakob Disease (CJD); CSF analysis should show elevated 14-3-3 protein.
- Wilson's Disease: A copper metabolism disorder presenting with liver failure and movement disorders, classically associated with Kayser-Fleischer rings in the eyes. Treatment involves chelating agents like penicillamine or trientine.
- Myasthenia Gravis (MG): Characterized by fluctuating muscle weakness that worsens with activity (e.g., difficulty keeping eyes open) due to autoantibodies against the acetylcholine receptor (A ChR) at the neuromuscular junction.
- Isoniazid (INH) Toxicity: INH is neurotoxic; deficiency of Vitamin B6 must be supplemented, as B6 is a cofactor for glutamate decarboxylase (GAD), preventing GABA synthesis and causing seizures/peripheral neuropathy.
- Demyelinating Syndromes: Differentiate between Multiple Sclerosis (MS) (CNS demyelination, affects oligodendrocytes) and Guillain-Barré Syndrome (GBS) (PNS demyelination, often post-infection).
- Ophthalmology Pearls: The wet form of Macular Degeneration is treated with Anti-VEGF inhibitors (e.g., Ranibizumab); BPPV causes vertigo triggered by positional changes in the semicircular canals.
Learning objectives
- Differentiate between various causes of dementia, including primary and secondary dementias.
- Recognize the clinical triad associated with Wilson's disease and its appropriate treatment.
- Master the pathophysiology and management of neuromuscular junction disorders like Myasthenia Gravis.
- Understand the neurotoxic effects of common antibiotics (e.g., INH) and necessary prophylactic supplementation.
- Apply knowledge of demyelinating diseases (MS vs GBS) based on CNS vs PNS involvement.
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Creutzfeldt-Jakob Disease (CJD) | Myoclonus, rapid dementia | Elevated CSF 14-3-3 protein | Always suspect CJD in rapidly progressive dementia with myoclonus. |
| Wilson's Disease | Kayser-Fleischer rings | Copper metabolism defect; Basal ganglia involvement | Treatment requires chelating agents (D-penicillamine/Trientine). |
| Myasthenia Gravis (MG) | Fluctuating weakness, ptosis | Autoantibodies against A ChR at NMJ | Weakness worsens with effort and improves with rest. |
| Isoniazid (INH) | Peripheral neuropathy, seizures | Vitamin B6 deficiency; GABA synthesis impairment | Always supplement Pyridoxine (B6) when treating TB with INH. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| Dementia | CJD vs AD vs Down Syndrome | Rapidly progressive dementia + myoclonus suggests CJD; early-onset/Down syndrome suggests AD. | Differentiating the speed and specific signs (myoclonus) is key for board questions. |
| Wilson's Disease | Copper overload, liver failure | Basal ganglia involvement; Kayser-Fleischer rings in corneas. | High yield association: copper metabolism defect. |
| BPPV | Positional vertigo | Otoconia displacement within the semicircular canals (canalithiasis). | The key is that the vertigo is positionally triggered and has no hearing loss. |
| INH Toxicity | B6 deficiency, GABA impairment | INH inhibits synthesis of porphyrins; B6 is needed for GAD enzyme. | Remember: Isoniazid -> Peripheral Neuropathy + Seizures (due to B6 depletion). |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient presents with progressive cognitive decline, myoclonus, and is an archaeologist. | Creutzfeldt-Jakob Disease (CJD) | The combination of rapid dementia, myoclonus, and the occupational history points strongly to CJD; CSF 14-3-3 elevation is classic. |
| A young patient presents with fluctuating ptosis and difficulty swallowing that worsens throughout the day. | Myasthenia Gravis (MG) | Fluctuating weakness worsening with activity is the hallmark of NMJ failure due to A ChR autoantibodies. |
| A male patient develops liver dysfunction, basal ganglia symptoms, and has copper deposition visible in his corneas. | Wilson's Disease | Copper overload affecting the liver and CNS, confirmed by Kayser-Fleischer rings. |
| A child presents with progressive weakness, fasciculations, and failure to achieve motor milestones. | Spinal Muscular Atrophy (SMA) | Progressive lower motor neuron signs (fasciculations, muscle wasting) starting in infancy are characteristic of anterior horn cell death due to genetic defects. |
| A patient develops tingling sensations in the hands after starting TB treatment with INH. | Peripheral Neuropathy (INH toxicity) | INH depletes Vitamin B6, which is essential for maintaining GABA levels and preventing peripheral nerve damage. |
| An elderly patient presents with acute onset of vertigo that is triggered by turning their head into bed. | Benign Paroxysmal Positional Vertigo (BPPV) | The positional nature of the vertigo points directly to otoconia displacement within the semicircular canals. |
Differential diagnosis / distinguishing features
Peripheral Neuropathies
| Key Features | Distinguishing Findings | Next Step |
| Guillain-Barré Syndrome (GBS) | Acute, ascending paralysis; areflexia; often post-infection/diarrhea. | Lumbar puncture may show albuminocytologic dissociation (low protein, normal WBC). |
| Spinal Muscular Atrophy (SMA) | Progressive weakness starting in infancy; fasciculations; LMN signs. | Genetic testing for SMN1 gene mutation. |
| Myasthenia Gravis (MG) | Fluctuating muscle weakness; worsens with effort. | Tensilon test or edrophonium challenge; A ChR antibody testing. |
Headache/Vertigo
| Key Features | Distinguishing Findings | Next Step |
| Benign Paroxysmal Positional Vertigo (BPPV) | Brief, intense vertigo triggered by specific head movements. | Dix-Hallpike maneuver (positive test). |
| Cluster Headache | Severe, unilateral pain; associated with autonomic symptoms (tearing, rhinorrhea). | Diagnosis of exclusion based on pattern and severity. |
Management pearls
- For suspected TIA: Always obtain a carotid ultrasound unless contraindicated, as this is the most common missing step in board questions.
- When treating Toxoplasmosis in immunocompromised patients (CD4 < 100): Use Pyrimethamine and Sulfadiazine for definitive treatment; TMP-SMX is primarily used for prophylaxis.
- For MG management: Treatment involves A ChR antibodies testing, followed by immunosuppression (steroids, rituximab) or acetylcholinesterase inhibitors (pyridostigmine).
- When managing INH toxicity: Supplementation with Pyridoxine (Vitamin B6) is mandatory to prevent peripheral neuropathy and seizures.
Don't miss
🚨
The classic presentation of a central demyelinating process is MS; the classic cranial nerves affected are II, III, IV, V, VI (though optic nerve II is from the neurotube).
🚨
Central vs Peripheral CN Palsies: Central lesions spare the pupil and often involve multiple roots/nerves. Peripheral lesions typically show "blood and thunder" appearance due to compromised blood supply.
🚨
AMD Treatment: The wet form requires Anti-VEGF inhibitors (e.g., Ranibizumab); the dry form is managed with antioxidants (Vitamin E).
🚨
SMA Pathophysiology: It is an anterior horn cell disease, leading to lower motor neuron signs and fasciculations.
Integration & clinical reasoning
- Pharmacology/Neurotoxicity: The mechanism of INH toxicity links biochemistry (B6 cofactor requirement for GAD) directly to clinical neurology (seizures/neuropathy).
- Infectious Disease/Immunosuppression: Understanding the CD4 count thresholds dictates whether prophylaxis (TMP-SMX) or aggressive treatment (Pyrimethamine/Sulfadiazine) is required for Toxoplasmosis.
- Ophthalmology/Neuro: The differential diagnosis between BPPV and other causes of vertigo requires a physical exam focused on positional triggers, not just hearing loss.
Concept connections / cross-references
- For detailed review of the central nervous system anatomy and pathology: Divine Intervention Episode 37 (or [Episode 37]).
- For comprehensive coverage of infectious disease management in immunocompromised hosts: Divine Intervention Episode 42 (or [Episode 42]).
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| Wilson's Disease | Basal Ganglia, Liver failure | Copper accumulation; impaired metallothionein function. | Requires chelation therapy to prevent irreversible neurological damage. |
| Myasthenia Gravis (MG) | Ptosis, diplopia, difficulty swallowing | Autoantibodies against the A ChR at the NMJ. | Diagnosis is highly suggestive based on fluctuating weakness and worsening with effort. |
| Isoniazid (INH) | Peripheral neuropathy, seizures | Depletion of Vitamin B6; impaired GABA synthesis via GAD enzyme. | Mandatory prophylactic Pyridoxine supplementation during treatment. |
| Toxoplasmosis | CD4 count < 100 cells/L | Opportunistic infection in immunosuppressed patients. | Requires specific drug regimens (Pyrimethamine + Sulfadiazine) for active disease. |
Key terms glossary
| Term | Definition | Context | Example |
| Myoclonus | Sudden, brief, involuntary muscle jerks. | Seen in CJD or metabolic encephalopathies. | A patient with CJD may exhibit spontaneous myoclonic jerks. |
| Kayser-Fleischer Rings | Copper deposits visible in the corneal limbus. | Pathognomonic sign of Wilson's disease. | Used for diagnosis when liver function tests are inconclusive. |
| A ChR | Acetylcholine receptor. | Target of autoantibodies in Myasthenia Gravis. | Antibodies block normal A Ch signaling at the neuromuscular junction. |
| 14-3-3 Protein | A protein found elevated in CSF during certain encephalopathies. | Highly suggestive, but not specific, marker for CJD. | Elevated levels support a diagnosis of prion disease. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Neurodegenerative Disorders | Focus on the rate and specific signs (e.g., myoclonus, early-onset) to differentiate AD vs CJD. | High | Review classic vignettes for each syndrome. |
| Pharmacology/Toxicity | Create a "Drug -> Deficiency -> System Affected" flow chart (INH -> B6 -> Peripheral Nerves). | Medium-High | Use mnemonics and association tables to memorize toxicities. |
| Ophthalmology/Neuro | Master the physical exam findings for vertigo (BPPV vs other causes) and vision loss (AMD types, CN palsies). | High | Practice differentiating central vs peripheral nerve deficits on diagrams. |
Question pattern recognition
- The "Classic Triad" Pattern: Identifying a specific combination of signs (e.g., liver failure + basal ganglia symptoms + Kayser-Fleischer rings = Wilson's disease).
- The "Toxicology/Supplementation" Pattern: Recognizing that certain drugs deplete essential cofactors (INH -> B6; etc.) and requiring mandatory supplementation.
- The "Differential Diagnosis by Progression" Pattern: Using the speed of decline (acute vs subacute vs chronic) to narrow down a diagnosis (e.g., CJD is rapid, AD is slow).
Test yourself
Common mistakes to avoid
🚫
Mistake 1: Confusing the type of AMD treatment. Do not treat wet AMD with Vitamin E; use Anti-VEGF inhibitors (e.g., Ranibizumab).
🚫
Mistake 2: Misinterpreting INH toxicity. Remember that B6 deficiency causes both peripheral neuropathy AND seizures because it impairs GABA synthesis via GAD.
🚫
Mistake 3: Confusing the cause of vertigo. Do not assume all positional vertigo is due to semicircular canal issues; always consider BPPV vs vestibular neuritis/labyrinthitis based on history and physical exam.
Common traps
⚠️
Trap 1 (CJD): The presence of myoclonus in a rapidly declining patient often leads students to think of metabolic causes, but the combination with dementia points strongly to CJD.
⚠️
Trap 2 (Toxoplasmosis): Students may confuse the prophylactic drug (TMP-SMX) with the definitive treatment drugs (Pyrimethamine/Sulfadiazine). Always check the CD4 count threshold and clinical status.
⚠️
Trap 3 (MG vs Myastenia Gravis Crisis): Be aware that severe MG can lead to a myasthenic crisis, which is an acute medical emergency requiring immediate IV therapy (e.g., IV Ig/Plasmapheresis).
OMM / COMLEX integration
🦴
High-Yield Viscerosomatics, Autonomics & COMAT Shelf Clinical Pearls:
- Cranial Nerves & Dura Mater Mechanics: The dura mater attaches firmly to the foramen magnum, C2, C3, and S2 (the reciprocal tension membrane). Craniosacral strains, particularly sphenobasilar synchondrosis (SBS) compression, restrict the cranial rhythmic impulse (normal CRI: 10–14 cycles/min).
- Jugular Foramen & Vagus Nerve Entrapment: The jugular foramen is formed by the petrous portion of the temporal bone and the occiput. Somatic dysfunction here compresses CN IX, X, and XI, leading to autonomic instability, dysphagia, or nausea. Suboccipital decompression frees the occipitoatlantal (OA) joint and improves CSF/venous drainage.
- Cervical Radiculopathy vs. Thoracic Outlet: In upper extremity neurological symptoms, differentiate cervical nerve root impingement (Spurling test) from thoracic outlet syndrome caused by tight anterior/middle scalenes (elevating rib 1) or pectoralis minor hypertonicity.